Pioneering work revealed that SCN5A modulates myelin degradation by macrophages in multiple sclerosis (MS) and that overexpression of the macrophage SCN5A variant in mice protects against murine experimental MS [28]. This evidence concerns the gene SCN5A and myeloid sarcoma.